- Home
- WRLD vs KRRO Comparison
WRLD vs KRRO Comparison
Compare WRLD & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WRLD | KRRO |
|---|---|---|
| Founded | 1962 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 683.3M | 58.6M |
| IPO Year | 1991 | 2019 |
Fundamental Metrics
Financial Performance| Metric | WRLD | KRRO |
|---|---|---|
| Price | $142.37 | $7.89 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $74.17 |
| AVG Volume (30 Days) | 96.7K | ★ 424.0K |
| Earning Date | 01-27-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 10.75 | N/A |
| Revenue | ★ $570,762,378.00 | $7,371,000.00 |
| Revenue This Year | $0.89 | $144.83 |
| Revenue Next Year | $3.51 | N/A |
| P/E Ratio | $13.76 | ★ N/A |
| Revenue Growth | ★ 2.33 | N/A |
| 52 Week Low | $104.99 | $5.20 |
| 52 Week High | $185.48 | $55.89 |
Technical Indicators
Market Signals| Indicator | WRLD | KRRO |
|---|---|---|
| Relative Strength Index (RSI) | 45.16 | 32.80 |
| Support Level | $141.87 | $7.63 |
| Resistance Level | $152.69 | $8.57 |
| Average True Range (ATR) | 6.88 | 0.69 |
| MACD | -0.23 | 1.24 |
| Stochastic Oscillator | 20.95 | 73.66 |
Price Performance
Historical ComparisonAbout WRLD World Acceptance Corporation
World Acceptance Corp operates a small-loan consumer finance business. The company offers short-term small installment loans, medium-term larger installment loans, related credit insurance and ancillary products and services to individuals. It also offers income tax return preparation services to its loan customers and other individuals. The Company operates 1,024 branches in Alabama, Georgia, Idaho, Illinois, Indiana, Kentucky, Louisiana, Mississippi, Missouri, New Mexico, Oklahoma, South Carolina, Texas, Tennessee, Utah, and Wisconsin.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.